Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-12-05

Clinical Trial Update: Gabapentin to Improve Patient Tolerance in Endoscopic Retrograde Cholangiopancreatography (ERCP) [NA]

View source ↗

Summary

Clinical trial update on gabapentin to improve patient tolerance in conscious sedation during ERCP; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

Sponsor: Indiana University | Conditions: Conscious Sedation | NA | Status: COMPLETED | Results posted: 2012-12-05